Spartan Fund Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Spartan Fund Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-75,000	Closed	-$4.2K	–	319
2023 Q3	$4.2K	Sell	75,000 -432,159	-85%	-$51.7K	﹤0.01%	209
2023 Q2	$20.9K	Buy	507,159 +432,159	+576%	+$44.7K	0.01%	210
2023 Q1	$6K	Hold	75,000	–	–	﹤0.01%	269
2022 Q4	$3K	Hold	75,000	–	–	﹤0.01%	349
2022 Q3	$11K	Buy	+75,000	New	+$8.36K	﹤0.01%	324

Spartan Fund Management's BIOSW Position: Q4 2023 in Review

Spartan Fund Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 75,000 shares — an estimated $4.2K sold.

Spartan Fund Management first reported a position in BIOSW in Q3 2022 and held it in 5 quarters. The position peaked at $20.9K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Spartan Fund Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Spartan Fund Management sold 75,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $4.2K.
Spartan Fund Management first reported a position in BioPlus Acquisition Corp. Warrants in Q3 2022 and held it in 5 quarters.
Spartan Fund Management's BioPlus Acquisition Corp. Warrants position peaked at $20.9K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Spartan Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.